PINNACLE FINANCIAL PARTNERS INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
PINNACLE FINANCIAL PARTNERS INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$674,451
-19.8%
17,871
-3.2%
0.02%
-19.0%
Q2 2023$841,128
+12.3%
18,4620.0%0.02%
+5.0%
Q1 2023$748,818
-25.3%
18,462
-6.1%
0.02%
-31.0%
Q4 2022$1,002,171
+193.0%
19,662
+209.3%
0.03%
+141.7%
Q3 2022$342,000
+1528.6%
6,357
+2548.8%
0.01%
+1100.0%
Q4 2021$21,000
+10.5%
2400.0%0.00%0.0%
Q3 2021$19,0000.0%2400.0%0.00%0.0%
Q2 2021$19,0000.0%2400.0%0.00%0.0%
Q1 2021$19,0000.0%2400.0%0.00%0.0%
Q4 2020$19,0000.0%2400.0%0.00%0.0%
Q3 2020$19,000
-9.5%
2400.0%0.00%0.0%
Q2 2020$21,000
+10.5%
2400.0%0.00%0.0%
Q1 2020$19,000
-91.5%
240
-91.0%
0.00%
-92.9%
Q4 2019$223,000
+3.7%
2,673
+8.8%
0.01%
-6.7%
Q3 2019$215,000
+975.0%
2,456
+923.3%
0.02%
+650.0%
Q1 2019$20,000
+5.3%
2400.0%0.00%0.0%
Q3 2018$19,000
+5.6%
2400.0%0.00%0.0%
Q2 2018$18,000
+12.5%
2400.0%0.00%0.0%
Q1 2018$16,000
-79.7%
240
-81.7%
0.00%
-81.8%
Q2 2017$79,000
+7800.0%
1,3150.01%
Q2 2016$1,0000.0%00.00%
Q1 2016$1,000
-99.6%
0
-100.0%
0.00%
-100.0%
Q4 2015$278,000
-24.0%
7,283
-34.6%
0.09%
-24.3%
Q3 2015$366,000
-47.6%
11,129
+11.5%
0.12%
-48.0%
Q2 2015$698,000
+69700.0%
9,9790.22%
Q1 2015$1,0000.0%00.00%
Q3 2014$1,0000.0%00.00%
Q1 2014$1,000
-95.2%
0
-100.0%
0.00%
-100.0%
Q3 2013$21,000
+2000.0%
3050.01%
+900.0%
Q2 2013$1,00000.00%
Other shareholders
BAXTER INTL INC shareholders Q3 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders